Valiant Organics Limited Announces FY 2026 Financial Results; Designates Pharma as Additional Reportable Segment
Valiant Organics Limited announced the results of its Board of Directors meeting held on May 16, 2026. During the meeting, the company approved the Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2026.Key decisions made by the Board included the identification of the Pharma Business as an additional reportable segment. This new segment status runs alongside the existing reportable segment, 'Specialty Chemicals', in line with the requirements of Indian Accounting Standard (Ind AS) 108 - Operating Segments.
Financial Results for FY 2026
The financial results reflect the company's operations for the year ended March 31, 2026.| Metric | Standalone (Rs. In Lakhs) | Consolidated (Rs. In Lakhs) |
|---|---|---|
| Total Income (Year Ended 31-Mar-2026) | 73,838.31 | 73,875.87 |
| Total Expenses (Year Ended 31-Mar-2026) | 70,795.98 | 70,834.52 |
| Profit/Loss Before Tax (Year Ended 31-Mar-2026) | 3,733.81 | 3,733.35 |
| Net Profit/Loss for the Period (Year Ended 31-Mar-2026) | 3,435.56 | 3,327.40 |
| Total Assets (As on 31-Mar-2026) | 113,085.48 | 123,079.42 |
| Total Equity & Liabilities (As on 31-Mar-2026) | 113,085.48 | 123,079.42 |
Segmental Breakdown
The company reported detailed segment information across both standalone and consolidated levels, highlighting the contributions of its key divisions.| Particulars | Speciality Chemical Division (31-Mar-2026) | Pharma Division (31-Mar-2026) | Total Income (31-Mar-2026) |
|---|---|---|---|
| Revenue from Operations (Rs. In Lakhs) | 16,947.11 | 4,822.91 | 21,770.02 |
| Total Income (Rs. In Lakhs) | 20,381.19 | 4750.75 | 25,131.94 |
| Segment Results before Interest and Tax (Rs. In Lakhs) | 2141.27 | 764.15 | 2905.42 |
Audit and Governance Updates
The Board also addressed key operational and governance areas:- Cost Auditor: Smt. Ketki D. Visariya was re-appointed as the Cost Auditor for the Financial Year 2026-27.
- Internal Auditor: M/s. Manish Modi & Associates, Chartered Accountants, were re-appointed as the Internal Auditor for FY 2026-27.
- Audit Opinion: The Statutory Auditors, Gokhale & Sathe, issued an audit report confirming an un-modified opinion on both the Standalone and Consolidated Financial Statements for the Financial Year ended March 31, 2026.
Financial Position Details
Detailed Balance Sheet and Cash Flow reports were also reviewed by the Board.Balance Sheet Summary (Rs. In Lakhs)
| Category | As on 31-Mar-2026 | As on 31-Mar-2025 |
|---|---|---|
| Total Assets | 113,085.48 | 107,931.58 |
| Total Equity & Liabilities | 123,079.42 | 118,292.87 |
Cash Flow from Operating Activities (Rs. In Lakhs)
| Metric | 31-Mar-2026 | 31-Mar-2025 |
|---|---|---|
| Net Profit for the period | 4,305.89 | 240.99 |
| Cash Generated from Operations | 4,175.82 | 5,856.00 |
| Net Cash Flow From Operating Activities | 4,428.99 | 5,643.22 |
The company confirmed that the unaudited financial results will be uploaded on its website for public access.
VALIANTORG Stock Price Movement
On Friday, Valiant Organics Limited shares edged higher, closing at ₹296.6 after rallying 4.05%. The stock saw a relatively active session, trading on 95,114 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.